Elevation Oncology OverviewElevation Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ELEV.
Quarterly EBIT
-$14.22M
↓ 44.05% YoY
As of Mar 31, 2025
Annual EBIT (TTM)
-$47.88M
↓ 24.12% YoY
Trailing 12 months ending Mar 31, 2025
Elevation Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for ELEV.
As of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025